Edition:
United States

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

8.76USD
16 Feb 2018
Change (% chg)

$0.65 (+8.01%)
Prev Close
$8.11
Open
$8.21
Day's High
$8.88
Day's Low
$8.17
Volume
214,300
Avg. Vol
131,594
52-wk High
$9.78
52-wk Low
$2.54

Chart for

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.99
Market Cap(Mil.): $446.60
Shares Outstanding(Mil.): 50.98
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

Earnings vs. Estimates